CARM Carisma Therapeutics Inc.

USD 1.10 0.00 0
Icon

Carisma Therapeutics Inc. (CARM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.10

0.00 (0.00)%

USD 0.05B

0.39M

USD 8.71(+692.21%)

N/A

Icon

CARM

Carisma Therapeutics Inc. (USD)
COMMON STOCK | NSD
USD 1.10
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.05B

N/A

USD 1.10

Carisma Therapeutics Inc. (CARM) Stock Forecast

Show ratings and price targets of :
USD 8.71
(+692.21%)

Based on the Carisma Therapeutics Inc. stock forecast from 3 analysts, the average analyst target price for Carisma Therapeutics Inc. is USD 8.71 over the next 12 months. Carisma Therapeutics Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Carisma Therapeutics Inc. is Bearish, which is based on 1 positive signals and 8 negative signals. At the last closing, Carisma Therapeutics Inc.’s stock price was USD 1.10. Carisma Therapeutics Inc.’s stock price has changed by -12.70% over the past week, +7.84% over the past month and -86.90% over the last year.

No recent analyst target price found for Carisma Therapeutics Inc.
No recent average analyst rating found for Carisma Therapeutics Inc.

Company Overview Carisma Therapeutics Inc.

Carisma Therapeutics, Inc., a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. The company's ex vivo CAR-M cell therapies include CT-0508, a CAR-macrophage, which is in Phas...Read More

https://www.carismatx.com

3675 Market Street, Philadelphia, PA, United States, 19104

107

December

USD

USA

Adjusted Closing Price for Carisma Therapeutics Inc. (CARM)

Loading...

Unadjusted Closing Price for Carisma Therapeutics Inc. (CARM)

Loading...

Share Trading Volume for Carisma Therapeutics Inc. Shares

Loading...

Compare Performance of Carisma Therapeutics Inc. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CARM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Carisma Therapeutics Inc. (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +4.34 (+0.88%) USD126.85B 31.94 20.00

ETFs Containing CARM

Symbol Name CARM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Carisma Therapeutics Inc. (CARM) Stock

Based on ratings from 3 analysts Carisma Therapeutics Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 7 buy, sell and hold ratings.

Unfortunately we do not have enough data on CARM's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for CARM is USD 8.71 over the next 12 months. The maximum analyst target price is USD 10 while the minimum anlayst target price is USD 6.

CARM stock's Price/Earning ratio is 21.38. Our analysis grades CARM stock's Price / Earning ratio at F. This means that CARM stock's Price/Earning ratio is above 72% of the stocks in the Biotechnology sector in the NSD exchange. Based on this CARM may be a overvalued for its sector.

The last closing price of CARM's stock was USD 1.10.

The most recent market capitalization for CARM is USD 0.05B.

Based on targets from 3 analysts, the average taret price for CARM is projected at USD 8.71 over the next 12 months. This means that CARM's stock price may go up by +692.21% over the next 12 months.

We can't find any ETFs which contains Carisma Therapeutics Inc.'s stock.

As per our most recent records Carisma Therapeutics Inc. has 107 Employees.

Carisma Therapeutics Inc.'s registered address is 3675 Market Street, Philadelphia, PA, United States, 19104. You can get more information about it from Carisma Therapeutics Inc.'s website at https://www.carismatx.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...